A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.84 NZD 1.43% Market Closed
Market Cap: 297.8m NZD
Have any thoughts about
AFT Pharmaceuticals Ltd?
Write Note

Relative Value

The Relative Value of one AFT stock under the Base Case scenario is 6.38 NZD. Compared to the current market price of 2.84 NZD, AFT Pharmaceuticals Ltd is Undervalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AFT Relative Value
Base Case
6.38 NZD
Undervaluation 56%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
60
Median 3Y
2.4
Median 5Y
2.9
Industry
2.5
Forward
1.3
vs History
69
vs Industry
24
Median 3Y
26.3
Median 5Y
33.8
Industry
21.8
Forward
17.4
vs History
90
vs Industry
34
Median 3Y
27.2
Median 5Y
31.1
Industry
16.1
vs History
69
vs Industry
19
Median 3Y
46.2
Median 5Y
46.2
Industry
23.8
vs History
98
vs Industry
22
Median 3Y
5.3
Median 5Y
6.8
Industry
2.1
vs History
98
vs Industry
57
Median 3Y
2.5
Median 5Y
3.1
Industry
2.7
Forward
1.4
vs History
98
vs Industry
51
Median 3Y
5.4
Median 5Y
6.6
Industry
5.2
vs History
88
vs Industry
27
Median 3Y
19.9
Median 5Y
21.5
Industry
13.5
Forward
13.5
vs History
88
vs Industry
31
Median 3Y
19.9
Median 5Y
21.5
Industry
16.8
Forward
18.3
vs History
90
vs Industry
34
Median 3Y
29.2
Median 5Y
32.9
Industry
15.2
vs History
71
vs Industry
22
Median 3Y
68.9
Median 5Y
56.8
Industry
19.3
vs History
96
vs Industry
28
Median 3Y
3.6
Median 5Y
4.1
Industry
1.9

Multiples Across Competitors

AFT Competitors Multiples
AFT Pharmaceuticals Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
AFT Pharmaceuticals Ltd
NZX:AFT
297.8m NZD 1.5 25.7 16.7 16.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
741.7B USD 18.1 88.1 47.6 53.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.8T DKK 10.3 29.6 20.5 23.5
US
Johnson & Johnson
NYSE:JNJ
346.4B USD 3.9 23.6 11.4 14.9
US
Merck & Co Inc
NYSE:MRK
250B USD 3.9 20.5 10.4 12.5
CH
Roche Holding AG
SIX:ROG
199.8B CHF 3.4 17.3 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.9
CH
Novartis AG
SIX:NOVN
171.7B CHF 3.8 10.9 9.5 13.2
US
Pfizer Inc
NYSE:PFE
148.7B USD 2.5 35 10.4 15.8
P/S Multiple
Revenue Growth P/S to Growth
NZ
A
AFT Pharmaceuticals Ltd
NZX:AFT
Average P/S: 382 942.1
1.5
47%
0
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
4 211 733
22%
194 879.4
US
Eli Lilly and Co
NYSE:LLY
18.1
109%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
29%
19.9
DK
Novo Nordisk A/S
CSE:NOVO B
10.3
77%
0.1
US
Johnson & Johnson
NYSE:JNJ
3.9
13%
0.3
US
Merck & Co Inc
NYSE:MRK
3.9
20%
0.2
CH
Roche Holding AG
SIX:ROG
3.4
15%
0.2
UK
AstraZeneca PLC
LSE:AZN
4.1
35%
0.1
CH
Novartis AG
SIX:NOVN
3.8
17%
0.2
US
Pfizer Inc
NYSE:PFE
2.5
10%
0.3
P/E Multiple
Earnings Growth P/E to Growth
NZ
A
AFT Pharmaceuticals Ltd
NZX:AFT
Average P/E: 31.4
25.7
85%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
88.1
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29.6
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.6
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.5
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.3
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.9
31%
0.3
US
Pfizer Inc
NYSE:PFE
35
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NZ
A
AFT Pharmaceuticals Ltd
NZX:AFT
Average EV/EBITDA: 415.2
16.7
77%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
47.6
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.5
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.4
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.4
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.5
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.4
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NZ
A
AFT Pharmaceuticals Ltd
NZX:AFT
Average EV/EBIT: 1 811.7
16.7
40%
0.4
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.1
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23.5
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.9
131%
1.9
CH
Novartis AG
SIX:NOVN
13.2
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.8
68%
0.2

See Also

Discover More
Back to Top